Clinical Trials Browser

Phase 1 × Recurrence × iberdomide × Clear all

NCT06215118 2026-05-22

MagnetisMM-30

Phase 1 Recruiting

Multiple Myeloma, Recurrence

NCT04464798 2025-04-29

A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

Phase 1 Terminated

Lymphoma, Recurrence